Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 67, 2003 - Issue 12
Journal homepage
221
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Neurite Outgrowth-stimulating Activities of β-Casomorphins in Neuro-2a Mouse Neuroblastoma Cells

Minoru SAKAGUCHILaboratory of Cell Biology, Osaka University of Pharmaceutical Sciences4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
,
Kouichi MURAYAMALaboratory of Cell Biology, Osaka University of Pharmaceutical Sciences4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
,
Yunden JINSMAADivision of Food Bioscience and Biotechnology, Graduate School of Agriculture, Kyoto UniversityUji, Kyoto 611-0011, Japan
,
Masaaki YOSHIKAWADivision of Food Bioscience and Biotechnology, Graduate School of Agriculture, Kyoto UniversityUji, Kyoto 611-0011, Japan
&
Eiko MATSUMURALaboratory of Cell Biology, Osaka University of Pharmaceutical Sciences4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
Pages 2541-2547 | Received 22 May 2003, Accepted 11 Sep 2003, Published online: 22 May 2014

  • 1) Brantl, V., Teschemacher, H., Henschen, A., and Lottspeich, F., Novel opioid peptides derived from casein (β-casomorphins). I. Isolation from bovine casein peptone. Hoppe-Seyler's Z Physiol. Chem., 360, 1211-1216 (1979).
  • 2) Chang, K.-J., Su, Y. F., Brent, D. A., and Chang, J.-K., Isolation of a specific μ-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteins. J. Biol. Chem., 260, 9706-9712 (1985).
  • 3) Brantl, V., Teschemacher, H., Blasig, J., Henschen, A., and Lottspeich, F., Opioid activities of β-casomorphins. Life Sci., 28, 1903-1909 (1981).
  • 4) Schlimme, E., and Meisel, H., Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Nahrung, 39, 1-20 (1995).
  • 5) Ramabadran, K., and Bansinath, M., Pharmacology of β-casomorphins, opioid peptides derived from milk protein. Asia Pacific J. Pharmacol., 4, 45-58 (1989).
  • 6) Svedberg, J., de Haas, J., Leimenstoll, G., Paul, F., and Teschemacher, H., Demonstration of β-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides, 6, 825-830 (1985).
  • 7) Meisel, H., and Frister, H., Chemical characterization of bioactive peptides from in vivo digests of casein. J. Dairy Res., 56, 343-349 (1989).
  • 8) Jinsmaa, Y., and Yoshikawa, M., Enzymatic release of neocasomorphin and β-casomorphin from bovine β-casein. Peptides, 20, 957-962 (1999).
  • 9) Hammer, R. P. Jr., and Hauser, K. F., Consequences of early exposure to opioids on cell proliferation and neuronal morphogenesis. In “Development of the Central Nervous System: Effects of Alcohol and Opiates”, ed. Miller, M. W., Wiley-Liss, New York, pp. 319-339 (1992).
  • 10) Hauser, K. F., and Stiene-Martin, A., Opiates and the regulation of nervous system development: evidence from in vitro studies. In “Neurobiology of Opiates”, ed. Hammer, R. P., CRC Press, Boca Raton FL, pp. 23-61 (1993).
  • 11) Sakaguchi, M., Murayama, K., Yabe, K., Satoh, M., Takeuchi, M., and Matsumura, E., β-Casomorphin-5 stimulates neurite outgrowth in a mouse neuroblastoma cell line (Neuro-2). Neurosci. Lett., 251, 97-100 (1998).
  • 12) Bottenstein, J. E., and Sato, G. H., Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA, 76, 514-517 (1979).
  • 13) Gurwitz, D., and Cunningham, D. D., Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. Natl. Acad. Sci. USA, 85, 3440-3444 (1988).
  • 14) Pihlanto-Leppala, A., Antila, P., Mantsala, P., and Hellman, J., Opioid peptides produced by in vitro proteolysis of bovine caseins. Int. Dairy J., 4, 291-301 (1994).
  • 15) Brantl, V., Pfeiffer, A., Herz, A., Henschen, A., and Lottspeich, F., Antinociceptive potencies of β-casomorphin analogs as compared to their affinity toward μ and δ-opiate receptor sites in brain and periphery. Peptides, 3, 793-797 (1982).
  • 16) Chang, K.-J., Cuatrecasas, P., Wei, E. T., and Chang, J.-K., Analgesic activity of intracerebroventricular administration of morphiceptin and β-casomorphins: Correlation with the morphin (μ) receptor binding affinity. Life Sci., 30, 1547-1552 (1982).
  • 17) Chang, K.-J., Killian, A., Hazum, E., Cuatrecasas, P., and Chang, J.-K., Morphiceptin (NH2-Tyr-Pro-Phe-Pro-CONH2): A potent and specific agonist for morphine (μ) recetpor. Science, 212, 75-77 (1981).
  • 18) Liebmann, C., Szüsz, M., Neubert, K., Hartrodt, B., Arold, H., and Barth, A., Opiate receptor binding affinities of some D-amino acid substituted β-casomorphin analogs. Peptides, 7, 195-199 (1986).
  • 19) Dhawan, B. N., Cesselin, F., Raghubir, R., Reisine, T., Bradly, P. B., Portoghese, P. S., and Hamon, M., International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev., 48, 567-592 (1996).
  • 20) Crain, S. M., and Shen, K.-F., Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol. Sci., 19, 358-365 (1998).
  • 21) Mitsui, K., Tsuji, S., Yamazaki, M., and Nagai, Y., Multiple neurite formation in neuroblastoma cell lines by griseolic acid, a potent inhibitor of cyclic nucleotide phosphodiesterases. J. Neurochem., 57, 556-561 (1991).
  • 22) Schnittler, M., Liebmann, C., Schrader, U., Schulze, H.-P., Neubert, K., and Repke, H., [3H]Naloxone as an opioid receptor label: Analysis of binding site heterogeneity and use for determination of opioid affinities of casomorphin analogues. Biomed. Biochim. Acta, 49, 209-218 (1990).
  • 23) Sakaguchi, M., Fujimori, T., Satoh, T., and Matsumura, E., Effects of β-casomorphins on neuronal survival in culture of embryonic chick dorsal root ganglion neurons. Jpn. J. Pharmacol., 86, 363-365 (2001).
  • 24) Zadina, J. E., Chang, S. L., Ge, L.-J., and Kastin, A. J., Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther., 265, 254-262 (1993).
  • 25) Sternini, C., Spann, M., Anton, B., Keith, D. E. Jr., Bunnett, N. W., von Zastrow, M., Evans, C., and Brecha, N. C., Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. USA, 93, 9241-9246 (1996).
  • 26) Pasternak, G. W., and Wood, P. J., Minireview: multiple opiate receptors. Life Sci., 38, 1889-1898 (1986).
  • 27) Ilyinsky, O. B., Kozlova, M. V., Kandrikova, E. S., Kalentchuk, U. V., Titov, M. I., and Bespalova, Zd. D., Effects of opioid peptides and naloxone on nervous tissue in culture. Neuroscience, 22, 719-735 (1987).
  • 28) Tenconi, B., Lesma, E., DiGiulio, A. M., and Gorio, A., High opioid doses inhibit whereas low doses enhance neuritogenesis in PC12 cells. Dev. Brain. Res., 94, 175-181 (1996).
  • 29) Ricalde, A. A., and Hammer, R. P., Perinatal opiate treatment delays growth of cortical dendrites. Neurosci. Lett., 115, 137-143 (1990).
  • 30) Sakellaridis, N., Mangoura, D., and Vernadakis, A., Effects of opiates on the growth of neuron-enriched cultures from chick embryonic brain. Int. J. Dev. Neurosci., 4, 293-302 (1986).
  • 31) Hauser, K. F., Gurwell, J. A., and Turbek, C. S., Morphine inhibits Purkinje cell survival and dendritic differentiation in organotypic cultures of the mouse cerebellum. Exp. Neurol., 130, 95-105 (1994).
  • 32) Hauser, K. F., Houdi, A. A., Turbek, C. S., Elde, R. P., and Maxson, W. III, Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of μ and δ receptor activation on proliferation and neurite elongation. Eur. J. Neurosci., 12, 1281-1293 (2000).
  • 33) Montminy, M., Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem., 66, 807-822 (1997).
  • 34) Li, L. Y., and Chang, K. J., The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol. Pharmacol., 50, 599-602 (1996).
  • 35) Ortiz, J., Harris, H. W., Guitart, X., Terwilliger, R. Z., Haycock, J. W., and Nestler, E. J., Extracellular signal-regulated protein Kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J. Neurosci., 15, 1285-1297 (1995).
  • 36) Singleton, D. W., Lu, C. L., Colella, R., and Roisen, F. J., Promotion of neurite outgrowth by protein kinases inhibitor and ganglioside GM1 in neuroblastoma cells involves MAP kinases ERK1/2. Int. J. Dev. Neurosci., 18, 797-805 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.